Name Funds
holding
Growth Growth % Return since
31 Mar ‘23
401
48 +6 +14% 2.94%
402
40 +5 +14% 55.5%
403
32 +4 +14% 93.2%
XLO icon
404
Xilio Therapeutics
XLO
$39.7M
32 +4 +14% 83%
405
24 +3 +14% 3.5%
406
24 +3 +14% 54.3%
407
24 +3 +14% 77.7%
408
16 +2 +14% 93.2%
409
16 +2 +14% 29.8%
410
8 +1 +14% 84%
UCC icon
411
ProShares Ultra Consumer Discretionary
UCC
$13M
8 +1 +14% 75.9%
412
8 +1 +14% 99.7%
413
8 +1 +14% 15.1%
414
8 +1 +14% 99.9%
415
8 +1 +14% 50.6%
416
8 +1 +14% 60.9%
417
8 +1 +14% 67.3%
418
8 +1 +14% 53%
419
41 +5 +14% 42.5%
420
33 +4 +14% 93.3%
421
75 +9 +14% 53.2%
422
75 +9 +14% 38.3%
423
50 +6 +14% 82.2%
424
25 +3 +14% 99%
425
25 +3 +14% 50.5%